Hostname: page-component-89b8bd64d-ksp62 Total loading time: 0 Render date: 2026-05-07T21:20:13.627Z Has data issue: false hasContentIssue false

Obesity and dietary fat influence dopamine neurotransmission: exploring the convergence of metabolic state, physiological stress, and inflammation on dopaminergic control of food intake

Published online by Cambridge University Press:  28 June 2021

Conner W. Wallace
Affiliation:
The Department of Nutrition, UNC Greensboro, Greensboro, NC 27412, USA
Steve C. Fordahl*
Affiliation:
The Department of Nutrition, UNC Greensboro, Greensboro, NC 27412, USA
*
*Corresponding author: Steve C. Fordahl, email scfordah@uncg.edu
Rights & Permissions [Opens in a new window]

Abstract

The aim of this review is to explore how metabolic changes induced by diets high in saturated fat (HFD) affect nucleus accumbens (NAc) dopamine neurotransmission and food intake, and to explore how stress and inflammation influence this process. Recent evidence linked diet-induced obesity and HFD with reduced dopamine release and reuptake. Altered dopamine neurotransmission could disrupt satiety circuits between NAc dopamine terminals and projections to the hypothalamus. The NAc directs learning and motivated behaviours based on homeostatic needs and psychological states. Therefore, impaired dopaminergic responses to palatable food could contribute to weight gain by disrupting responses to food cues or stress, which impacts type and quantity of food consumed. Specifically, saturated fat promotes neuronal resistance to anorectic hormones and activation of immune cells that release proinflammatory cytokines. Insulin has been shown to regulate dopamine neurotransmission by enhancing satiety, but less is known about effects of diet-induced stress. Therefore, changes to dopamine signalling due to HFD warrant further examination to characterise crosstalk of cytokines with endocrine and neurotransmitter signals. A HFD promotes a proinflammatory environment that may disrupt neuronal endocrine function and dopamine signalling that could be exacerbated by the hypothalamic–pituitary–adrenal and κ-opioid receptor stress systems. Together, these adaptive changes may dysregulate eating by changing NAc dopamine during hedonic versus homeostatic food intake. This could drive palatable food cravings during energy restriction and hinder weight loss. Understanding links between HFD and dopamine neurotransmission will inform treatment strategies for diet-induced obesity and identify molecular candidates for targeted therapeutics.

Information

Type
Review Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s), 2021. Published by Cambridge University Press on behalf of The Nutrition Society
Figure 0

Fig. 1. Effects of dietary fat and obesity on hedonic and homeostatic dopamine circuits: homeostatic, dopamine-motivated feeding and reward learning circuits overlap as insulin and leptin convey body energy status to the hypothalamus (Hypo) and VTA. In response, hypothalamic nuclei send appetitive neuropeptides to the VTA and NAc to influence food intake, and NAc dopamine neurotransmission is directly stimulated by hormonal action in the NAc and VTA. This information is also conveyed via dopamine, GABA and glutamate from the VTA to NAc, and the NAc responds by sending GABA to hypothalamic feeding regions, the VTA as a regulatory feedback circuit, and thalamic, motor and cognitive cortical regions. Effects of long-term HFD or palatable food consumption are highlighted by region. This characterises how diet-induced obesity dysregulates key neurotransmitters, neuropeptides and hormones that regulate food intake to reduce dopamine neurotransmission leading to overeating and further weight gain.TH, tyrosine hydroxylase; D1R/D2R, dopamine type 1/2 receptors; DAT, dopamine transporter; POMC/CART, pro-opiomelanocortin/cocaine- and amphetamine-regulated transcript; NPY/AGRP, neuropeptide Y/agouti-related peptide.

Figure 1

Fig. 2. Effect of acute stress on dopamine neurotransmission and palatable food intake: acute exposures to stress engage the PVN and promote sympathetic and HPA axis activation leading to direct engagement of dopamine pathways. Downstream, glucocorticoid response and promotion of anorectic versus orexigenic neuropeptides inhibit food intake. However, acute stress associated with short-term removal of HFD activates stress systems that may persist for extended periods to promote seeking and intake of palatable foods. Further, activation of stress systems may reduce chow intake but promote consumption of palatable foods that acutely activate NAc dopamine neurotransmission and provide an alternate ‘avoidance or escape’ behaviour.ACTH, adrenocorticotropin; CORT, corticosterone/cortisol; CRF, corticotrophin-releasing factor; NPY, neuropeptide Y; POMC, pro-opiomelanocortin; AGRP, agouti-related peptide; HPA, hypothalamic–pituitary–adrenal; KOR, κ-opioid receptor; Δ, change.

Figure 2

Fig. 3. Chronic stress alters dopamine and promotes consumption of palatable food: repeated stress exposures, including long-term physiological stresses related to diet-induced obesity, chronically up-regulate stress pathways to promote orexigenic neuropeptides, inflammation and hormonal resistance. This leads to dysregulation of dopamine and increased food intake, weight gain and anxio-depressive behaviours. However, consumption of palatable foods during stress activates the dopamine system and reduces metabolic and behavioural responsivity to stress, highlighting stress alleviative properties of palatable foods. Behavioural and pharmacological interventions which improve diet-induced alterations to inflammatory, hormonal, stress and dopamine systems may reduce craving, seeking and consumption of highly palatable foods for obese individuals attempting to lose weight.CORT, corticosterone/cortisol; NPY, neuropeptide Y; AGRP, agouti-related peptide; POMC, pro-opiomelanocortin; D1R/D2R, dopamine type 1 or type 2 receptor; TH, tyrosine hydroxylase; KOR, κ-opioid receptor; CRF, corticotrophin-releasing factor; Δ, change.